Interline Therapeutics

290 Utah Ave, Suite 300
South San Francisco
CA
94080
United States

Show jobs for this employer

4 articles with Interline Therapeutics

With New Funds, Foresite's Bajaj Outlines Coming Life Sciences Transformation

3/3/2022

Foresite Labs CEO Vikram Bajaj believes that data science will fundamentally transform the life sciences and translate into the development of new therapeutics for various disease states.
Foresite Labs Hatches Big-Data-Driven Companies Destined to Shake up Healthcare

1/20/2022

Such a deep, data-driven approach is enabling precision medicine, in particular, which is expanding from oncology to autoimmune diseases and other conditions.
Top Life Sciences Startups to Watch in 2022

1/6/2022

BioSpace is proud to present its NextGen Bio “Class of 2022,” a list of up-and-coming life sciences companies in North America that recently launched.
Interline Will Focus $92 Million Investment to Advance Precision Medicine Platform

5/14/2021

Foresite Labs-incubated company Interline Therapeutics announced Thursday that it had raised $92 million in a financing round co-led by Foresite Capital and ARCH Venture Partners.